Lainie Jones has Li-Fraumeni syndrome, which makes her predisposed to having cancer. She's undergoing treatment for ...
Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...
Clea Shearer opens up to PEOPLE about the latest and unexpected surgery in her breast cancer journey, and how she’s using her ...
Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...
7don MSN
The comedian, 60, is appearing in a new Super Bowl ad to raise awareness for breast cancer. She says she 'feels great' after ...
Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...
15h
Hosted on MSNBlood Test for Early Pancreatic Cancer Shows PromiseHe noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...
Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...
Dr Scott Tagawa discusses how dose adjustments can optimize the use of enfortumab vedotin in urothelial cancer.
Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results